About 40 percent of American women have obesity; about 75 percent of breast cancers are estrogen-receptor positive, most of which will go on to be treated with anti-estrogen therapies. This combination means that thousands of women every year could benefit from treatments aimed at the aspects of obesity that promote breast cancer in low- or non-estrogen environments.
I encourage everybody in the cancer community to watch First in Human and see the impact of the remarkable work being done by NCI researchers and the clinical staff who care for patients every day in the NIH Clinical Center.
A new study conducted primarily in mice suggests that chemotherapy given before surgery for breast cancer can cause changes in cells in and around the tumor that are tied to an increased risk of the cancer spreading to other areas of the body. However, the study also identifies an experimental therapy that could potentially reduce this risk.
Steer clear of non-stick cookware (with the exception of cookware that uses only ceramics to avoid sticking), as it is known to contain toxic chemicals. If you want to avoid metals leaching into your foods altogether, stick with stainless steel or ceramic cookware.
Unfortunately, the majority of people who are diagnosed with cancer report some change in sexual function, because of either cancer or cancer treatment,” says Sharon Bober, founder and director of the Sexual Health Program for Cancer Patients and Survivors at the Dana-Farber Cancer Institute. Bober explains that treatment’s impact on sexuality and sexual function is broad; the side effects are myriad.
Ten years ago, Fumiko Chino was the art director at a television production company in Houston, engaged to be married to a young Ph.D. candidate. Today, she’s a radiation oncologist at Duke University, studying the effects of financial strain on cancer patients. And she’s a widow. How she got from there to here is a story about how health care and money are intertwined in ways that doctors and patients don’t like to talk about. Chino is co-author of a research letter, published in JAMA Oncology, that shows that some cancer patients, even with insurance, spend about a third of their household income on out-of-pocket health care costs outside of insurance premiums.
While I have learned so much along the way about all of the myths connected to breast cancer, I do think that we must always put things into proper perspectives. Until such times as the scientific community is able to figure out how and why we get cancer, perhaps we should focus on dealing with our own individual treatment and healing. While we are given certain guidelines to hopefully improve our chances of not getting cancer, we all know people who have religiously lived by those guidelines and still got cancer. Therefore, since we can’t change the past, we do ourselves a major favor if we choose to focus on our present and the future.
Recent headlines about the possible export of chlorine-washed chicken from the United States to Britain have caused an uproar. And while Britain has vowed not to accept the trade deal, the headlines have left many wondering what exactly is chlorine-washed chicken?
The findings of the Environmental Working Group’s (EWG) Tap Water Database may be shocking to many Americans, as they show that the drinking water supplies of nearly everyone in the nation are tainted with chemicals at levels exceeding at least one health-protective guideline. If you’re concerned about what’s in your water, buying a water filter is a smart next step. In conjunction with the database, EWG has released an updated Water Filter Buying Guide.
Last year, the Swiss Medical Board, an independent health technology assessment initiative, was asked to prepare a review of mammography screening. The team of experts on the board included a medical ethicist, a clinical epidemiologist, a pharmacologist, an oncologic surgeon, a nurse scientist, a lawyer, and a health economist. After a year of reviewing the available evidence and its implications, they noted they became “increasingly concerned” about what they were finding. The “evidence” simply did not back up the global consensus of other experts in the field suggesting that mammograms were safe and capable of saving lives. On the contrary, mammography appeared to be preventing only one death for every 1,000 women screened, while causing harm to many more. Their thorough review left them no choice but to recommend that no new systematic mammography screening programs be introduced, and that a time limit should be placed on existing programs. In their report, the Swiss Medical Board also advised that the quality of mammography screening should be evaluated and women should be informed, in a “clear and balanced” way, about the benefits and harms of screening. The report caused an uproar among the Swiss medical community, but it echoes growing sentiments around the globe that mammography for breast cancer screening in asymptomatic populations no longer makes sense.
The University of Wisconsin-Madison is studying “exceptional survivors” of metastatic breast cancer. These women continue to live while others die despite the same or better prognosis.
Choosing a cheaper health plan could cost you access to cream-of-the-crop cancer doctors and facilities, a new study reports. Less-expensive “narrow network” health plans are much less likely to cover treatment by doctors at centers affiliated with the U.S. National Cancer Institute, said study lead author Laura Yasaitis.
The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals.
“The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases,” Chris Hansen, president of the American Cancer Society Cancer Action Network, said in a network news release. “Yet costs remain a challenge for those facing cancer. Our country and our lawmakers should come together to find bipartisan solutions that begin to address patient costs without sacrificing the quality of coverage,” he urged.
Does sparing the nipple increase the risk of cancer coming back? Not according to new research conducted at Massachusetts General Hospital, and published in the Journal of the American College of Surgeons.
According to a New York Times story, contaminants such as mercury, lead and bacteria, and other banned ingredients, are showing up in an alarming number of imported personal care products. This follows recent news that asbestos was found in tests of imported makeup marketed to tweens.
The findings of the IMPORT LOW trial, published in the journal The Lancet, showed that women who received partial radiotherapy reported fewer long-term changes to the appearance and feel of their breast than those who had radiotherapy to the whole breast. Further, five years after treatment, almost all patients were disease-free, the researchers said.
People who are diagnosed with oestrogen-sensitive breast cancer – which accounts for around 80 per cent of breast cancers, the most common cancer in women – respond well to treatment. But some patients are at particular risk of dying when it returns, especially after about five years. The new research helps identify people who belong to that sub-group, in a move towards avoiding those relapses. It also means that those who aren’t part of those groups may be able to avoid chemotherapy.
Here is a simple technique to help people avoid saying the wrong thing. It works for all kinds of crises: medical, legal, financial, romantic, even existential. It’s called the Ring Theory.
Many beauty and skin care products on the market are full of hidden chemicals, and makeup products may be the worst. If you want to be healthy and still use foundation and eyeliner, you may be wondering: Is it possible to wear makeup without harming your body with toxic chemicals? Yes, just like you can swap out harsh cleaning products and get rid of toxic food, you can change out your makeup.
The Food and Drug Administration (FDA) has cleared a cooling cap—a device designed to reduce hair loss during chemotherapy—for use by patients with any kind of solid tumor. FDA initially cleared the device, the DigniCap® Scalp Cooling System, for patients with breast cancer in 2015.